Sort content by
FIS Harvard 2019

Healthcare’s multiple opportunities

William Haseltine had a long career at Harvard Medical School, educating a generation of doctors, and designing the strategy to develop the first treatment for HIV/AIDS. He addressed the Fiduciary Investors Symposium about important topics in medicine and health development.
Sarah RundellOctober 14, 2019
FIS Harvard 2014

The biggest risk for investors is misunderstanding uncertainty

As the focus of retirees shifts ever-further towards objectives-based outcomes, those entrusted with achieving those objectives will have to rethink a traditional approach to managing money involving risk and return trade-offs. Speaking at the Fiduciary Investors Symposium (FIS) at Harvard University, Abdallah Nauphal, chief executive and chief investment officer of Insight Investment, a BNY Mellon […]
Simon HoyleOctober 28, 2014
FIS Harvard 2014

Good for Harvard, good for the world: Why HMC embraced ESG with a passion

Harvard Management Corporation (HMC) signed up to the UN-supported Principles for Responsible Investment (PRI) less than a year ago, but the company that manages the $36 billion Harvard University endowment is already moving rapidly to build environmental, social and governance (ESG) factors into every investment decision it makes. Jane Mendillo, president and chief executive of […]
Simon HoyleOctober 28, 2014
FIS Harvard 2014

G20 urged to develop policies to support long-term investment

The Fiduciary Investors Symposium (FIS) at Harvard University has identified several of the key barriers to pension funds, endowments and sovereign wealth funds adopting more effective long-term and sustainable investment strategies, and is preparing a communiqué to the upcoming meeting of the G20 to convey its concerns and its policy requirements. FIS, organised and hosted […]
Simon HoyleOctober 27, 2014
<1of2>